The assessment of patient life-expectancy: How accurate are urologists and oncologists?

BJU International

Volumn 95, Issue 6, 2005, Pages 794-798

  Wilson, James R M ^a   Clarke, Michael G ^a   Ewings, Paul ^a   Graham, John D ^b   MacDonagh, Ruaraidh ^a  

^a TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Actuarial; Comorbidity; Life expectancy; Prostate cancer

Indexed keywords

ADULT; AGED; CONFERENCE PAPER; DECISION MAKING; DIAGNOSTIC ACCURACY; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; ONCOLOGY; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; UROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CLINICAL COMPETENCE; COMORBIDITY; CONSULTANTS; HUMANS; LIFE EXPECTANCY; MALE; MEDICAL ONCOLOGY; MEDICAL STAFF, HOSPITAL; MIDDLE AGED; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; UROLOGY;

EID: 17444372698     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05403.x     Document Type: Conference Paper

References (19)

1. Wilson J, Graham J, MacDonagh R. Patient life-expectancy: a vital element in planning treatment? BJU Int 2004; 93: 461-3
2. Royal College of Radiologists' Clinical Oncology Information Network British Association of Urological Surgeons. Guidelines on the management of prostate cancer. BJU Int 1999; 84: 987-1014
3. Alibhai SMH, Krahn MD, Cohen MM et al. Is there age bias in the treatment of localized prostate cancer? Cancer 2004; 100: 72-81
4. Krahn MD, Bremner KE, Asaria J et al. The ten-year rule revisited, accuracy of clinicians' estimates of life expectancy in patients with localised prostate cancer. Urology 2002; 60: 258-63
5. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc 1968; 16: 622-6
6. Greenfield S, Aronow HU, Elashoff RM, Watanabe D. Flaws in mortality data, the hazards of ignoring comorbid disease. JAMA 1988; 260: 2253-5
7. Goldman L, Caldera DL, Nussbaum SR et al. Multifactorial index of cardiac risk in noncardiac surgical procedures N Engl J Med 1977; 297: 845-50
8. Copeland GP, Jones D, Walters M. POSSUM, a scoring system for surgical audit. Br J Surg 1991; 78: 355-60
9. Singh R, O'Brien TS. Comorbidity assessment in localized prostate cancer. A review of currently available techniques. Eur Urol 2004; 46: 28-41
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 1987; 40: 373-83
11. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245-51
12. Post PN, Kil PJ, Hendrikx AJ, Janssen-Heijnen ML, Crommelin MA, Coebergh JW. Comorbidity in patients with prostate cancer and its relevance to treatment choice. BJU Int 1999; 84: 652-6
13. Barry MJ, Albertsen PC, Bagshaw MA et al. Outcomes for men with clinically non-metastatic prostate carcinoma managed with radical prostatectomy, external beam radiotherapy, or expectant management: a retrospective analysis. Cancer 2001; 91: 2302-14
14. Kaplan MH, Feinstein AR. The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 1974; 27: 387-404
15. http://www.oto.wustl.edu/clinepi/Forms/com_form.doc
16. Picirillo JF, Lacy PD, Basu A, Spitznagel EL. Development of a new head and neck cancer-specific comorbidity index. Arch Otolaryngol Head Neck Surg 2002; 128: 1172-9
17. Brackenridge RDC, Elder JW. Medical selection of life risks. Macmillan Reference 1998
18. Koch MO, Miller DA, Butler R et al. Are we selecting the right patients for treatment of localized prostate cancer? Results of an actuarial analysis. Urology 1998; 51: 197-202
19. Kirwan JR. Clinical judgement in rheumatoid arthritis. I. Rheumatologists' opinions and the development of paper patients. Ann Rheum Dis 1983; 42: 644-7